Keywords
How to Cite
Abstract
Hypertension is one of the most common diseases encountered in primary care settings and a major risk factor for cardiovascular disease. Secondary hypertension is common in patients with hypertension diagnosis; its prevalence is about 10% and can be as high as 40% in patients whom are resistant to treatment. Its early recognition and treatment allows for better outcomes. Objective: To evaluate and identify the main causes for secondary hypertension and to identify the diagnosis and evaluation of related conditions. Methods: Selection and review of articles from Pubmed and Google scholar and literature reviews from Uptodate. Conclusions: It is important to identify secondary hypertension since this will modify treatment, outcomes and in some scenarios might be curable.
Pullalarevu R, Akbar G, Teehan G. Secondary hypertensionn issues in diagnosis and treatment. Prim Care. 2014;41(4). doi: http://dx.doi.org/10.1016/j.pop.2014.08.001.
Rimoldi S, Scherrer U, Messerli F. Secondary arterial hypertension: When, who, and how to screen? Eur Heart J. 2014;35(19):1245-54. doi: http://dx.doi.org/10.1093/eurheartj/eht534.
Textor S, Bakirs G, Kaplan N. Evaluation of secondary hypertension [internet]. 2015 jul [citado 24 oct 2016]. Disponible en: https://www.uptodate.com/contents/evaluation-of-secondary-hypertension?source=search_result&search=evaluation %20secondary %20hypertension&selectedTitle=1~150.
Viera A, Neutza D. Diagnosis of secondary hypertensión: an age based approach. Am Fam Physician [Internet]. 2010 Dic [citado 25 oct 2016];82(12). Disponible en: http://www.aafp.org/afp/2010/1215/p1471.html.
Li F, Huang H, Song L, Hao H, Ying M. Effects of obstructive sleep apnea hypopnea syndrome on blood pressure and C-Reactive protein in male hypertension patients. J Clin Med Res. 2016;8(3):220-4. doi: http://dx.doi.org/10.14740/jocmr2409w.
Preston R, Singer I, Epstein M. Renal pareqnchymal hypertension. Arch Intern Med. 1996;156(6):602-11. doi: http://dx.doi.org/10.1001/archinte.1996.00440060016002
Bumgartner I, Lerman L. Renovascular hypertension: Screening and modern management. Eur Heart J. 2011;32(13):1590-8. doi: http://dx.doi.org/10.1093/eurheartj/ehq510.
Tafur J, White C. Renal artery stenosis. Cardiology Clinics. 2015;33(4):59-73. doi: http://dx.doi.org/10.1016/j.ccl.2014.09.006.
Cohen D, Twonsend R. Secondary hypertension: Diagnosis and management of an adrenal adenoma. J Clin Outcomes Manag [intenet]. 2002 [citado 25 oct 2016];9(9):525-32. Disponible en: http://www.turner-white.com/pdf/jcom_sep02_adrenal.pdf.
Uwaifo G, Khardori R. Primary aldosteronism. Medscape [internet]. 2016 Jun [citado 25 oct 2016]. Disponible en: https://emedicine.medscape.com/article/127080-overview.
Nguyen L, Cook S. Coarctation of the aorta, strategies for improving outcomes. Cardiology Clinics. 2015;33(4):521-530. doi: http://dx.doi.org/10.1016/j.ccl.2015.07.011
Prisant M, Mawulawde K, Kapoor D, Joe C. Coarctation of the aorta: A secondary cause of hypertension. J Clin Hypertension. 2004;6(6):347-52. doi: http://dx.doi.org/10.1111/j.1524-6175.2004.02868.x
This journal is registered under a Creative Commons Attribution 4.0 International Public License. Thus, this work may be reproduced, distributed, and publicly shared in digital format, as long as the names of the authors and Pontificia Universidad Javeriana are acknowledged. Others are allowed to quote, adapt, transform, auto-archive, republish, and create based on this material, for any purpose (even commercial ones), provided the authorship is duly acknowledged, a link to the original work is provided, and it is specified if changes have been made. Pontificia Universidad Javeriana does not hold the rights of published works and the authors are solely responsible for the contents of their works; they keep the moral, intellectual, privacy, and publicity rights.
Approving the intervention of the work (review, copy-editing, translation, layout) and the following outreach, are granted through an use license and not through an assignment of rights. This means the journal and Pontificia Universidad Javeriana cannot be held responsible for any ethical malpractice by the authors. As a consequence of the protection granted by the use license, the journal is not required to publish recantations or modify information already published, unless the errata stems from the editorial management process. Publishing contents in this journal does not generate royalties for contributors.